Last night, RPS in Scotland hosted its first “Personalised Medicine” reception and debate in the Scottish Parliament outlining the crucial role pharmacists play in personalising medicines now and in the future.
Sponsored by Fulton MacGregor MSP, the main focus of the debate was the impact of personalised medicine on our health, healthcare and resources. Before moving on to the panel debate attendees heard from Professor Christine Bond (Chair of the Royal Pharmaceutical Society Pharmaceutical Science Expert Advisory Panel (RPS PSEAP)), who outlined how the work the RPS is taking forward in relation to personalised medicine sits within the wider work of the panel and its ‘New Medicines, Better Medicines, Better Use of Medicines - A Guide to the Science Underpinning Pharmaceutical Practice’ document, which it launched in 2014.
The panel discussion saw key contributions from Professor Gino Martini (RPS PSEAP), Sandra Auld (Director ABPI Scotland & UK Therapy Groups), Professor David Newby (British Heart Foundation John Wheatley Chair of Cardiology, University of Edinburgh, Board Member, Stratified Medicine Scotland – Innovation Centre), Steve McGlynn (Specialist Principal Pharmacist (Cardiology), NHS Greater Glasgow and Clyde) and Sally Arnison (Pharmacist Independent Prescriber, Barnton Pharmacy).
Alex MacKinnon, Director for Scotland, said: “Pharmacists are playing an increasingly important role in health technology appraisal and pharmaceutical care, helping to ensure that patients have timely access to clinically effective and cost-effective personalised medicine. Increasingly, community pharmacies as the most accessible access point in the NHS, could become the principal focus for people to access evidence-based medicines information, receive their follow up care and advice on therapeutic options.”
Full video form the event is available to watch below:
Photographs from the event are available below: